Copyright
©2012 Baishideng.
World J Psychiatr. Oct 22, 2012; 2(5): 74-82
Published online Oct 22, 2012. doi: 10.5498/wjp.v2.i5.74
Published online Oct 22, 2012. doi: 10.5498/wjp.v2.i5.74
Table 1 Adherence evaluation methods
| Direct | Indirect |
| Detection of the drug or drug metabolites | Objective |
| Direct observation | Tablet count |
| Electronic monitoring | |
| Pharmacy records | |
| Subjective | |
| Psychometric scales | |
| Questioning the patient | |
| Questioning the relatives | |
| Clinical judgment |
Table 2 Identified risk factors for non-adherence by patients with schizophrenia
| Patient-related risk factors |
| Sociodemographic factors |
| Younger and older patients |
| Male |
| General clinical factors |
| Drugs or alcohol consumption |
| Previous non-adherence |
| Psychopathological symptoms |
| Impaired insight |
| Cognitive deficiency |
| Delusion of persecution, poisoning or grandeur |
| Psychotic symptoms |
| Negative symptoms |
| Psychological factors: attitudes, beliefs and other subjective aspects |
| Negative attitude toward the treatment |
| Negative subjective response to treatment |
| Regarding the disease as mild and/or perceived minor benefit from treatment |
| Shame or stigmatization associated with the medication or the disease |
| Environment-related risk factors |
| Poor social and familial support |
| Negative social perception of the disease |
| Stigmatization |
| Difficulty accessing healthcare services |
| Physician-related risk factors |
| Poor relationship with the therapist |
| Poor psychoeducation and information to patients and relatives |
| Poor contact with the therapist |
| Inadequate planning of the post-discharge period |
| Treatment-related risk factors |
| Ineffectiveness against persistent symptoms (psychotic and negative symptoms) |
| Fear of adverse effects |
| Complex medication schedule |
| Poorer adherence to oral than to intramuscular treatments |
- Citation: Acosta FJ, Hernández JL, Pereira J, Herrera J, Rodríguez CJ. Medication adherence in schizophrenia. World J Psychiatr 2012; 2(5): 74-82
- URL: https://www.wjgnet.com/2220-3206/full/v2/i5/74.htm
- DOI: https://dx.doi.org/10.5498/wjp.v2.i5.74
